| Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive E Jacinto, R Loewith, A Schmidt, S Lin, MA Rüegg, A Hall, MN Hall Nature cell biology 6 (11), 1122-1128, 2004 | 2738 | 2004 |
| Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control R Loewith, E Jacinto, S Wullschleger, A Lorberg, JL Crespo, D Bonenfant, ... Molecular cell 10 (3), 457-468, 2002 | 2338 | 2002 |
| SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity E Jacinto, V Facchinetti, D Liu, N Soto, S Wei, SY Jung, Q Huang, J Qin, ... Cell 127 (1), 125-137, 2006 | 1749 | 2006 |
| JNK is involved in signal integration during costimulation of T lymphocytes B Su, E Jacinto, M Hibi, T Kallunki, M Karin, Y Ben-Neriah Cell 77 (5), 727-736, 1994 | 1155 | 1994 |
| Tor signalling in bugs, brain and brawn E Jacinto, MN Hall Nature reviews Molecular cell biology 4 (2), 117-126, 2003 | 753 | 2003 |
| mTOR complex 2 signaling and functions WJ Oh, E Jacinto Cell cycle 10 (14), 2305-2316, 2011 | 692 | 2011 |
| The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C V Facchinetti, W Ouyang, H Wei, N Soto, A Lazorchak, C Gould, C Lowry, ... The EMBO journal 27 (14), 1932-1943, 2008 | 644 | 2008 |
| mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide WJ Oh, C Wu, SJ Kim, V Facchinetti, LA Julien, M Finlan, PP Roux, B Su, ... The EMBO journal 29 (23), 3939-3951, 2010 | 374 | 2010 |
| Calcineurin preferentially synergizes with PKC‐θ to activate JNK and IL‐2 promoter in T lymphocytes G Werlen, E Jacinto, Y Xia, M Karin The EMBO journal, 1998 | 350 | 1998 |
| Regulation and metabolic functions of mTORC1 and mTORC2 A Szwed, E Kim, E Jacinto Physiological reviews 101 (3), 1371-1426, 2021 | 308 | 2021 |
| TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway E Jacinto, B Guo, KT Arndt, T Schmelzle, MN Hall Molecular cell 8 (5), 1017-1026, 2001 | 290 | 2001 |
| TOR regulation of AGC kinases in yeast and mammals E Jacinto, A Lorberg Biochemical Journal 410 (1), 19-37, 2008 | 253 | 2008 |
| Targeting mTOR and metabolism in cancer: lessons and innovations C Magaway, E Kim, E Jacinto Cells 8 (12), 1584, 2019 | 178 | 2019 |
| Molecular Cloning and Characterization of Human JNKK2, a Novel Jun NH2-Terminal Kinase-Specific Kinase Z Wu, J Wu, E Jacinto, M Karin Molecular and cellular biology 17 (12), 7407-7416, 1997 | 148 | 1997 |
| Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes E Jacinto, G Werlen, M Karin Immunity 8 (1), 31-41, 1998 | 147 | 1998 |
| Quantitation of changes in protein phosphorylation: a simple method based on stable isotope labeling and mass spectrometry D Bonenfant, T Schmelzle, E Jacinto, JL Crespo, T Mini, MN Hall, P Jenoe Proceedings of the National Academy of Sciences 100 (3), 880-885, 2003 | 143 | 2003 |
| mTORC2 responds to glutamine catabolite levels to modulate the hexosamine biosynthesis enzyme GFAT1 JG Moloughney, PK Kim, NM Vega-Cotto, CC Wu, S Zhang, M Adlam, ... Molecular cell 63 (5), 811-826, 2016 | 118 | 2016 |
| mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8 SJ Kim, MA DeStefano, WJ Oh, C Wu, NM Vega-Cotto, M Finlan, D Liu, ... Molecular cell 48 (6), 875-887, 2012 | 108 | 2012 |
| Mammalian TOR signaling to the AGC kinases B Su, E Jacinto Critical reviews in biochemistry and molecular biology 46 (6), 527-547, 2011 | 85 | 2011 |
| What controls TOR? E Jacinto IUBMB life 60 (8), 483-496, 2008 | 55 | 2008 |
